Delivery strategies of cancer immunotherapy: recent advances and future perspectives
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-29
DOI
10.1186/s13045-019-0817-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
- (2019) Elizabeth K. Duperret et al. Cancer Immunology Research
- Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
- (2019) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
- (2018) Yuanyuan Liu et al. Acta Biomaterialia
- Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
- (2018) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- Toll-like Receptor Agonist Conjugation: A Chemical Perspective
- (2018) Bob J. Ignacio et al. BIOCONJUGATE CHEMISTRY
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity
- (2018) Pengxiang Yang et al. NANO LETTERS
- Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy
- (2018) Keman Cheng et al. NANO LETTERS
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
- (2018) Alexander S Cheung et al. NATURE BIOTECHNOLOGY
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiorenal complications of immune checkpoint inhibitors
- (2018) Krishna Sury et al. Nature Reviews Nephrology
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
- (2018) Yuan Zhang et al. Nature Communications
- Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
- (2018) Susan Hua et al. Frontiers in Pharmacology
- Enterocolitis due to immune checkpoint inhibitors: a systematic review
- (2018) Emilie Soularue et al. GUT
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Cancer immunotherapy: challenges and clinical applications
- (2018) An-Liang Xia et al. JOURNAL OF MEDICAL GENETICS
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
- (2017) Guoying Zhou et al. GASTROENTEROLOGY
- Recent progress in GM-CSF-based cancer immunotherapy
- (2017) Wan-Lun Yan et al. Immunotherapy
- Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
- (2017) Tyrel T. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- (2017) Jarushka Naidoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
- (2017) Jun Ishihara et al. Science Translational Medicine
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Dendritic cells in host response to biologic scaffolds
- (2017) Cynthia A. Leifer SEMINARS IN IMMUNOLOGY
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities
- (2017) An-Liang Xia et al. Oncotarget
- Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation
- (2017) Catia S. Verbeke et al. Advanced Healthcare Materials
- Injectable hydrogels for cartilage and bone tissue engineering
- (2017) Mei Liu et al. Bone Research
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
- (2017) Hirayuki Enomoto et al. Scientific Reports
- Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors
- (2016) Yanqi Ye et al. ACS Nano
- Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody
- (2016) Chao Wang et al. ADVANCED MATERIALS
- Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy
- (2016) Chao Liang et al. CHEMICAL SOCIETY REVIEWS
- Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
- (2016) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Biomaterials for enhancing anti-cancer immunity
- (2016) Sandeep T Koshy et al. CURRENT OPINION IN BIOTECHNOLOGY
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Materials and methods for delivery of biological drugs
- (2016) Alexander N. Zelikin et al. Nature Chemistry
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
- (2016) Hok Hei Tam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
- (2016) N. Arenas-Ramirez et al. Science Translational Medicine
- Advances in Cancer Immunotherapy in Solid Tumors
- (2016) Smitha Menon et al. Cancers
- Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer
- (2015) Sima Rahimian et al. BIOMATERIALS
- Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
- (2015) Chi-Ping Day et al. CELL
- Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
- (2015) G. Schreibelt et al. CLINICAL CANCER RESEARCH
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Interferons and viruses: an evolutionary arms race of molecular interactions
- (2015) Hans-Heinrich Hoffmann et al. TRENDS IN IMMUNOLOGY
- Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines
- (2015) Gregory Lee Szeto et al. Scientific Reports
- Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells
- (2015) Catia S. Verbeke et al. Advanced Healthcare Materials
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm
- (2015) James L. Gulley et al. OncoImmunology
- Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
- (2015) Yongkui Li et al. OncoImmunology
- Ex Vivo Cytosolic Delivery of Functional Macromolecules to Immune Cells
- (2015) Armon Sharei et al. PLoS One
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- Nanoparticle-Based Immunotherapy for Cancer
- (2014) Kun Shao et al. ACS Nano
- Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
- (2014) Karlo Perica et al. ACS Nano
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Biopolymer implants enhance the efficacy of adoptive T-cell therapy
- (2014) Sirkka B Stephan et al. NATURE BIOTECHNOLOGY
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
- (2014) Jaeyun Kim et al. NATURE BIOTECHNOLOGY
- A carbon nanotube–polymer composite for T-cell therapy
- (2014) Tarek R. Fadel et al. Nature Nanotechnology
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Tumor Angiogenesis by Interferon-γ by Suppression of Tumor-Associated Macrophage Differentiation
- (2014) Tao Sun et al. ONCOLOGY RESEARCH
- Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
- (2013) Joel C. Sunshine et al. BIOMATERIALS
- Injectable, porous, and cell-responsive gelatin cryogels
- (2013) Sandeep T. Koshy et al. BIOMATERIALS
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- A vector-free microfluidic platform for intracellular delivery
- (2013) A. Sharei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
- (2013) Laura M. Alwan et al. Targeted Oncology
- Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
- (2012) Matthias T. Stephan et al. BIOMATERIALS
- Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
- (2012) Jason Park et al. NATURE MATERIALS
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells
- (2012) J. Dirks et al. Transplant Infectious Disease
- Nanomedicine for Cancer: Lipid-Based Nanostructures for Drug Delivery and Monitoring
- (2011) Yoshihisa Namiki et al. ACCOUNTS OF CHEMICAL RESEARCH
- Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
- (2011) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature
- (2011) Guru Sonpavde et al. EUROPEAN UROLOGY
- The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue
- (2011) Omar A. Ali et al. JOURNAL OF CONTROLLED RELEASE
- An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma
- (2011) Ankur Singh et al. JOURNAL OF CONTROLLED RELEASE
- The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses
- (2011) Brenda De Keersmaecker et al. JOURNAL OF LEUKOCYTE BIOLOGY
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- Cytokines and the inception of CD8 T cell responses
- (2011) Maureen A. Cox et al. TRENDS IN IMMUNOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- DNA vaccines: an historical perspective and view to the future
- (2010) Margaret A. Liu IMMUNOLOGICAL REVIEWS
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
- (2010) Matthias T Stephan et al. NATURE MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity
- (2010) Barney S. Graham et al. PLoS One
- Polymers for Drug Delivery Systems
- (2010) William B. Liechty et al. Annual Review of Chemical and Biomolecular Engineering
- In vitro performance of an injectable hydrogel/microsphere based immunocyte delivery system for localised anti-tumour activity
- (2009) Chunming Wang et al. BIOMATERIALS
- In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA–DNA carrying microparticles to dendritic cells
- (2009) Ankur Singh et al. BIOMATERIALS
- Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
- (2009) K. S. Peggs et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Infection-mimicking materials to program dendritic cells in situ
- (2009) Omar A. Ali et al. NATURE MATERIALS
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
- (2009) S. Z. Ben-Sasson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
- (2009) O. A. Ali et al. Science Translational Medicine
- Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors
- (2008) Yuki Hori et al. Acta Biomaterialia
- Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy
- (2008) Yuki Hori et al. BIOMATERIALS
- Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells
- (2008) Hetty J. Bontkes et al. CLINICAL IMMUNOLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now